Transgene Biotek Ltd — Insider Trading, 20-12-2025: Insider Trading / SAST

Transgene Biotek has announced the closure of its trading window for designated persons, their immediate relatives, and connected individuals. This measure, in line with the company's code of conduct, commences on January 1, 2026, and will remain in effect until 48 hours after the declaration of the financial results for the quarter ended December 31, 2025. The company will announce the date of the Board Meeting to consider these results in due course. This action ensures fair trading practices ahead of the quarterly financial disclosure.